WallStreetZenWallStreetZen

NASDAQ: IPHA
Innate Pharma Sa Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Innate Pharma Sa revenue was $11.25M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IPHA annual revenue was $10.6M, with -49.5% growth year-over-year.

IPHA past revenue growth

How has IPHA's revenue growth performed historically?

Company
-24.68%
Industry
263.5%
Market
35.1%
IPHA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IPHA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IPHA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IPHA revenue history

Current Revenue
$11.2M
Current Earnings
-$54.2M
Current Profit Margin
-483.8%

Be the first to know when IPHA announces revenue.

IPHA Revenue History By Year

IPHA Yearly RevenueIPHA RevenueIPHA ChangeIPHA Revenue Growth
2025-12-31$10.58M-$10.36M-49.46%
2024-12-31$20.94M-$47.32M-69.33%
2023-12-31$68.26M$6.78M+11.02%
2022-12-31$61.49M$33.51M+119.78%
2021-12-31$27.98M-$57.85M-67.40%
2020-12-31$85.82M-$10.19M-10.61%
2019-12-31$96.01M-$11.98M-11.09%
2018-12-31$107.99M$55.13M+104.29%
2017-12-31$52.86MN/AN/A

1 of 1

Innate Pharma Sa Revenue FAQ

What was IPHA's revenue last quarter?

On Sep 17, 2026, Innate Pharma Sa (NASDAQ: IPHA) reported Q2 2026 revenue of N/A up N/A year over year. In the same quarter last year, Innate Pharma Sa's revenue was N/A.

What was Innate Pharma Sa's revenue in 2025?

Innate Pharma Sa's annual revenue for the twelve months ending Dec 31, 2025 was $10.58 million, a 49.46% decrease year over year.

How much does Innate Pharma Sa make in a day?

Based on Innate Pharma Sa annual revenue for the past five years, IPHA makes an average of $103,695.37 per day.

What was Innate Pharma Sa's annual revenue growth in the past year?

As of Q3 2026, Innate Pharma Sa's revenue has grown -24.68% year over year. This is 288.18 percentage points lower than the US Biotechnology industry revenue growth rate of 263.5%. Innate Pharma Sa's revenue in the past year totaled $11.25 million.

How much does Innate Pharma Sa make in a year?

Innate Pharma Sa's revenue by year for the past five years is:
  • Innate Pharma Sa's revenue for the twelve months ending Dec 31, 2025 was $10.58 million, a 49.46% decrease year over year.
  • Innate Pharma Sa's annual revenue for Dec 31, 2024 was $20.94 million, a 69.33% decrease from 2023.
  • Innate Pharma Sa's annual revenue for 2023 was $68.26 million, a 11.02% increase from 2022.
  • Innate Pharma Sa's annual revenue for 2022 was $61.49 million, a 119.78% increase from 2021.
  • Innate Pharma Sa's annual revenue for 2021 was $27.98 million, a 67.4% decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.